- Home
- EVMN vs MEG Comparison
EVMN vs MEG Comparison
Compare EVMN & MEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVMN | MEG |
|---|---|---|
| Founded | 2020 | 2012 |
| Country | United States | United States |
| Employees | 48 | 3500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 825.5M | 930.8M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | EVMN | MEG |
|---|---|---|
| Price | $22.49 | $22.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $43.88 | $35.25 |
| AVG Volume (30 Days) | ★ 281.9K | 241.5K |
| Earning Date | 06-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 93.69 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $830,538,000.00 |
| Revenue This Year | N/A | $5.41 |
| Revenue Next Year | N/A | $7.19 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.26 |
| 52 Week Low | $13.89 | $19.00 |
| 52 Week High | $33.20 | $32.00 |
Technical Indicators
Market Signals| Indicator | EVMN | MEG |
|---|---|---|
| Relative Strength Index (RSI) | 41.18 | 52.09 |
| Support Level | $21.39 | $20.80 |
| Resistance Level | $25.50 | $23.48 |
| Average True Range (ATR) | 1.60 | 0.79 |
| MACD | -0.25 | 0.13 |
| Stochastic Oscillator | 10.55 | 88.92 |
Price Performance
Historical ComparisonAbout EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
About MEG Montrose Environmental Group Inc.
Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits and permits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, and soil remediation. The company derives maximum revenue from United States.